|
Clinical outcomes 0–12 months |
|||||||
| Item |
N |
0 months |
12 months |
0 months vs. 12 months |
|||
|
|
|||||||
| Mean (SD) |
Mean (SD) |
P-value |
Median difference (95%-CI)* |
Improved |
SRM |
||
|
|
|||||||
| Disease Score (0–10) |
237 |
6.65 (1.81) |
3.19 (2.27) |
p < 0.001 |
4.00 (3.50 to 4.00) |
87% |
1.34 |
| Symptom Score (0–10) |
336 |
5.95 (1.75) |
3.49 (2.12) |
p < 0.001 |
2.50 (2.25 to 2.75) |
84% |
1.04 |
| SF-36 scales (0–100) |
|||||||
| -Physical Function |
270 |
75.34 (22.74) |
83.18 (19.41) |
p < 0.001 |
10.00 (7.50 to 10.00) |
63% |
0.42 |
| -Role Physical |
267 |
42.51 (39.20) |
67.79 (37.20) |
p < 0.001 |
37.50 (37.50 to 50.00) |
55% |
0.63 |
| -Role-Emotional |
268 |
47.26 (41.87) |
70.58 (38.09) |
p < 0.001 |
33.34 (33.30 to 50.00) |
49% |
0.55 |
| -Social Functioning |
272 |
62.13 (25.75) |
75.28 (24.37) |
p < 0.001 |
18.75 (12.50 to 25.00) |
58% |
0.49 |
| -Mental Health |
271 |
54.21 (18.65) |
65.05 (19.00) |
p < 0.001 |
12.00 (8.00 to 14.00) |
71% |
0.57 |
| -Bodily Pain |
272 |
55.91 (28.41) |
66.93 (27.65) |
p < 0.001 |
16.00 (11.50 to 20.00) |
55% |
0.41 |
| -Vitality |
271 |
38.68 (17.85) |
51.49 (18.68) |
p < 0.001 |
15.00 (12.50 to 17.50) |
68% |
0.67 |
| -General Health |
268 |
50.86 (18.80) |
58.39 (19.55) |
p < 0.001 |
8.50 (6.00 to 10.00) |
65% |
0.44 |
| SF-36 Health Change (1–5**) |
272 |
3.23 (1.08) |
2.15 (1.09) |
p < 0.001 |
1.50 (1.00 to 1.50) |
69% |
0.68 |
| SF-36 Physical Component |
263 |
43.13 (10.25) |
47.10 (9.78) |
p < 0.001 |
3.90 (2.83 to 4.97) |
68% |
0.44 |
| SF-36 Mental Component |
263 |
38.31 (11.67) |
45.01 (11.76) |
p < 0.001 |
6.45 (4.94 to 7.96) |
69% |
0.55 |
| KINDL subscales (0–100) |
|||||||
| -Psychic |
35 |
67,36 (15,27) |
70,68 (15,64) |
p = 0.188 |
3.41 (-2.27 to 9.09) |
60% |
0.20 |
| -Somatic |
35 |
70,57 (14,47) |
75,60 (9,35) |
p = 0.071 |
4.17 (0.00 to 9.72) |
66% |
0.37 |
| -Social |
35 |
69,90 (11,95) |
73,16 (11,78) |
p = 0.063 |
4.17 (0.00 to 7.29) |
66% |
0.28 |
| -Function |
33 |
64,39 (14,33) |
67,94 (10,44) |
p = 0.187 |
3.41 (-2.27 to 7.96) |
61% |
0.25 |
| KINDL Summary Score (0–100) |
35 |
67.86 (11.02) |
71.48 (9.79) |
p = 0.063 |
3.59 (-0.07 to 7.65) |
63% |
0.34 |
| KITA subscales (0–100) |
|||||||
| -Psychosoma |
51 |
69.53 (15.45) |
77.21 (13.60) |
p = 0.001 |
9.38 (4.17 to 12.50) |
69% |
0.51 |
| -Daily Life |
56 |
59.23 (21.78) |
68.14 (18.52) |
p = 0.001 |
10.42 (4.17 to 14.58) |
63% |
0.53 |
|
*Positive differences indicate improvement. Improved: Percentage of patients improved from baseline. **1 = "much better now than one year ago", 5 = "much worse now than one year ago". SRM: Standardised Response Mean effect size (small: 0.20–0.49, medium: 0.50–0.79, large: ≥ 0.80). | |||||||
Hamre et al. BMC Public Health 2007 7:61 doi:10.1186/1471-2458-7-61 |
|||||||